Reimbursed with a limitationGenericATC L01EA01

Imatinib GIST-Teva

Imatinib GIST-Teva is a generic from Teva Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 581.10 to CHF 1'129.80 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
Teva Pharma AG
ATC code
L01EA01
IT group
07.16.10 Cytostatica
Active substances
Imatinibum
Preparation type
Generic
On the SL since
01/11/2020
Last price change
01/12/2023
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Imatinib GIST-Teva Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 100 mgBlist 60 StkCHF 519.23CHF 581.1001/11/2020A7680666210017
Filmtabl 400 mgBlist 30 StkCHF 1'023.74CHF 1'129.8001/11/2020A7680666210024

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/11/2020

Zur Behandlung unresezierbarer und/oder metastasierter maligner gastrointestinaler Stromatumoren (GIST) bei Erwachsenen.
Zur adjuvanten Behandlung Erwachsener mit relevantem Risiko eines Rezidivs nach Resektion KIT-(CD117)-positiver GIST: Patienten mit einem niedrigen Rezidivrisiko sollen keine adjuvante Behandlung erhalten.

More preparations in this group

FAQ

Is Imatinib GIST-Teva covered by Swiss health insurance?

Yes, but only under conditions. Imatinib GIST-Teva is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Imatinib GIST-Teva cost in Switzerland?

The public price is the maximum price set by the FOPH and for Imatinib GIST-Teva ranges from CHF 581.10 to CHF 1'129.80 per pack. The ex-factory price ranges from CHF 519.23 to CHF 1'023.74. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com